EP4234581
Meðferðarmótefni og notkun þeirra
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
30.3.2016EP published:
17.9.2025EP application number:
23171630.9
EP translation filed:
3.11.2025Grant published:
15.12.2025EPO information:
European Patent Register
Max expiry date:
29.3.2036Expiry date:
29.3.2027Next due date:
31.3.2027
Title in English:
THERAPEUTIC ANTIBODIES AND THEIR USESLanguage of the patent:
English
Timeline
Today
30.3.2016EP application
17.9.2025EP Publication
3.11.2025Translation submitted
15.12.2025Registration published
29.3.2027Expires
Owner
Name:
Pfizer Inc.Address:
66 Hudson Boulevard East, New York, NY 10001-2192, US
Inventor
Name:
KUO, Tracy Chia-ChienAddress:
San Mateo, CA 94401, US
Name:
CHAPARRO RIGGERS, Javier FernandoAddress:
San Mateo, CA 94401, US
Name:
CHEN, WeiAddress:
Cupertino, CA 95014, US
Name:
CHEN, Amy Shaw-RuAddress:
San Jose, CA 95129, US
Name:
PASCUA, Edward DerrickAddress:
Oakland, CA 94612, US
Name:
VAN BLARCOM, Thomas JohnAddress:
Oakland, CA 94611, US
Name:
BOUSTANY, Leila MarieAddress:
Redwood City, CA 94062, US
Name:
HO, WeihsienAddress:
Belmont, CA 94002, US
Name:
YEUNG, Yik AndyAddress:
South San Francisco, CA 94080, US
Name:
STROP, PavelAddress:
San Mateo, CA 94403, US
Name:
RAJPAL, ArvindAddress:
San Francisco, CA 94127, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201562146843 PDate:
13.4.2015Country:
US
Number:
201562146504 PDate:
13.4.2015Country:
US
Number:
201662301582 PDate:
29.2.2016Country:
US
Supplementary protection
SPC number:
SPC541
Classification
Categories:
A61K 39/395, A61K 47/68, C07K 16/28, A61K 39/00
Annual fees
Number
Paid
Expires
Payer
Number: 11
Paid: 5.1.2026
Expires: 29.3.2027
Payer: Árnason Faktor ehf.